Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
GOSS
#3275
Gossamer Bio, Inc. Common Stock
0.4
2
+7.69%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+7.69%
Monatliche Änderung
-84.33%
6 month change
-83.00%
Jahresänderung
-63.16%
Vorheriger Schlusskurs
0.3
9
Open
0.4
2
Bid
Ask
Low
0.4
2
High
0.4
3
Volumen
101
Märkte
Aktien
Gesundheitswesen
GOSS
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
75.53 M
76.48 M
94.98 M
225.58 M
227.22 M
—
Valuation ratios
Enterprise value
244.3 M
681.55 M
81.8 M
186.71 M
159.47 M
1.23 B
Price to earnings ratio
—
-3.61
-0.75
-0.82
-3.62
-14.5
Price to sales ratio
—
—
—
203.92
1.78
24.25
Price to cash flow ratio
—
-4.48
-0.92
-0.93
-59.01
-37.89
Price to book ratio
—
6.97
14.29
2.36
6.94
11.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.45
0.68
0.84
0.58
0.18
0.63
Return on equity %
0.76
1.93
18.99
2.86
1.92
8.4
Return on invested capital %
3 387.39
2 497.3
2 002.56
2 122.48
844.13
—
Gross margin %
100
—
—
100
100
400
Operating margin %
91.39 K
—
—
25.31 K
52.24
353.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
95.06 K
—
—
24.77 K
49.28
1 418.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
13.51
8.32
5.32
5.94
6.88
20.28
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0.37
0.16
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.05
0.08
0.04
0
0
—
Long term debt to total equity ratio
0.09
0.24
0.99
0.01
0
—
Per share metrics
Operating cash flow per share
—
2.52
2.21
1.04
0.02
0.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.35
3.02
1.94
1.3
6.75
Net current asset value per share
—
4.43
3.1
2.01
1.37
4.52
Tangible book value per share
—
1.62
0.14
0.41
0.13
0.72
Working capital per share
—
3.9
2.51
1.67
1.17
3.6
Book value per share
—
1.62
0.14
0.41
0.13
0.72
Nachrichten
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
Wedbush stuft Gossamer-Bio-Aktie nach enttäuschenden Studienergebnissen herab
Gossamer Bio stock downgraded by Wedbush on trial results
Enttäuschende Studiendaten: Barclays stuft Gossamer-Bio-Aktie herab
Barclays cuts Gossamer Bio stock rating on trial results
Studiendaten verfehlt: Leerink stuft Gossamer-Bio-Aktie ab
Leerink cuts Gossamer Bio stock rating on trial miss
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%
Tesla, Oracle among market cap stock movers on Monday
American Express, Oracle among market cap stock movers on Monday